The role of ascorbic acid, selenium, and glutathione on benzo[a]pyrene-induced carcinogenesis in wistar rats

Journal of B.U.ON.

Volumn 9, Issue 2, 2004, Pages 187-192

  Charalabopoulos, K ^a   Karkabounas, S ^a   Dimicco, P ^b   Binolis, J ^a   Charalabopoulos, A ^a   Zelovitis, J ^a   Avdikos, A ^a   Metsios, A ^a   Peschos, D ^c   Agnantis, N J ^c   Evangelou, A ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Ascorbic acid; Benzo a pyrene; Carcinogenesis; Glutathione; Selenium; Wistar rats

Indexed keywords

ASCORBIC ACID; BENZO[A]PYRENE; GLUTATHIONE; SODIUM SELENITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CALCULATION; CANCER INCIDENCE; CANCER SURGERY; CANCER SURVIVAL; CARCINOGENICITY; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DEATH; HISTOPATHOLOGY; IN VIVO STUDY; INJECTION; NONHUMAN; RAT; RAT STRAIN; STATISTICAL SIGNIFICANCE; SURVIVAL TIME;

EID: 4344598925     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Allison AC, Nash T. Electron donation and acceptance by carcinogenic compounds. Nature 1963; 197: 758-763.
2. Evangelou A, Kalpouzos G, Karkabounas S et al. Dose related preventive and therapeutic effects of antioxidants-anticarcinogens on experimentally induced malignant tumors in wistar rats. Cancer Lett 1997; 115: 105-111.
3. Charalabopoulos K, Karkabounas S, Ioachim E et al. Anti-tumour and toxic effects on wistar rats of two new platinum complexes. Eur J Clin Invest 2002; 2: 129-133.
4. Franceschi S, Bidoli E, Negri E et al. Role of macronutrients, vitamins and minerals in the aetiology of squamous cell carcinoma of the oesophagus. Int J Cancer 2000; 86: 625-631.
5. Charalabopoulos K, Karkabounas S, Zelovitis J et al. Role of ascorbic acid during chemical carcinogenesis induced by benzo(a)pyrene in wistar rats. 6th World Hellenic Biomed Congr, Athens, Greece, 2000, p 141.
6. Cameron E, Pauling L. Ascorbic acid and the glycosaminoglycans: An orthomolecular approach to cancer and other diseases. Oncology 1973; 27: 181-193.
7. Alaejos MS, Diaz Romero FJ, Diaz Romero C. Selenium and cancer: some nutritional aspects. Nutrition 2000; 16: 376-383.
8. Jacob RA. The role of micronutrients in DNA synthesis and maintenance. Adv Exp Med Biol 1999; 472: 101-103.
9. 2 with 5′-IMP and 5′-GMP. J Inorg Biochem 1998; 72: 133-140.
10. 3 toxicity and antitumour activity benzo(a)pyrene treated wistar rats. Metal Ions Biol Med 2000; 6: 591-593.
11. Katsarou E, Charalabopoulos K, Hadjiliadis N. Ternary complexes of cis-DDP with guo, cyd, and the amino acids gly, nval, ala, 2-aba nval and nleu. Metal Based Drugs 1997; 4: 57-63.
12. Charalabopoulos K, Karkabounas S, Papalimneou V, Vezyraki P, Kalfakakou V, Evangelou A. Chemical carcinogens and inactivating substances. Eur Assoc Cancer Res XVI, Salonika, Greece, 2000, GP12, p100.
13. Coffey RN, Watson RW, Hegarty NJ et al. Thiol mediated apoptosis in prostate carcinoma cells. Cancer 2000; 88: 2092-2104.
14. Berenblum I. Two stage mechanism of carcinogenesis as an analytical tool. In: Emelot P, Mühlbock O (eds): Cellular control mechanism and cancer. Academic Press, New York, 1964, pp 249-268.
15. Arcos JC, Argus MF. Molecular geometry and carcinogenic activity of aromatic compounds. Adv Cancer Res 1968; 11: 305-314.
16. Miller JA. Carcinogenesis by chemicals. Cancer Res 1970; 30: 559-576.
17. Miller EC, Miller JA. Molecular Biology of Cancer. In: Busche H (ed): Molecular Biology of Cancer. Academic Press, New York, 1974, p 377.
18. Sakagami H, Fujiwara E, Yokote Y et al. Changes in intercellular concentrations of amino acids and polyamines during the apoptosis of HL-60 cells. Anticancer Res 2000; 20: 265-270.
19. Shklar G, Oh SK. Experimental basis for cancer prevention by vitamin E. Cancer Invest 2000; 18: 214-222.
20. Francheschi S. Nutrients and food groups and large bowel cancer in Europe. Eur J Cancer Prev 1999; (Suppl 1): 49-52.
21. Gelboin HV. A microsome-dependent binding of benzo(a) pyrene to DNA. Cancer Res 1969; 29: 1272-1277.
22. Wu K, Helzlsouer KJ, Alberg AJ, Comstock GW, Norkus EP, Hoffman SC. A prospective study of plasma ascorbic acid concentrations and breast cancer. Cancer Causes Control 2000; 11: 279-283.
23. Kaiser HE, Krenn M, Bodey B Jr, Bodley B. Growth inhibitors in the treatment of malignant neoplasms. In Vivo 2000; 14: 287-296.
24. Halliwell B. The antioxidant paradox. Lancet 2000; 355: 1179-1180.
25. Evangelou A. Vanadium in cancer treatment. Crit Rev Oncol Hematol 2002; 42: 249-265.
26. Magalova T, Bella V, Bitkova A, Beno I, Kulackova M, Volkovova K. Copper, zinc, and superoxide desmoutase in precancerous, benign diseases, gastric, colorectal and breast cancer. Neoplasma 1999; 46: 100-104.
27. Davies SM, Robinson LL, Buckley JD, Radloff GA, Ross JA, Perentesis JP. Glutathione S-tranferase polymorphisms in children with myeloid leukemia. Cancer Epid Biom Prev 2000; 9: 563-566.
28. Lang CA, Mills BJ, Mastopaolo W, Zin MC. Blood glutathione decreases in chronic diseases. J Lab Clin Med 2000; 135: 402-408.
29. Lin G, Ghadirian V, Vesprini D et al. Polymorphism in GSTM1, GSTT1 and CYP1A1 and risk of pancreatic adenocarcinoma. Br J Cancer 2000; 82: 1646-1649.